SynthesisPloS one2018

Indirect treatment comparison of cabazitaxel for patients with metastatic castrate-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen.

Jon P Fryzek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.